Mucopolysaccharidosis type V. (Scheie syndrome). A postmortem study by multidisciplinary techniques with emphasis on the brain

Arch Pathol Lab Med. 1976 May;100(5):237-45.

Abstract

Multidisciplinary studies were conducted on the brain and other tissues of patients who died with the antemortem diagnosis of mucopolysaccharidosis (MPS) of one of the following types; type V, Scheie disease (MPS-V); type I, Hurler disease (MPS-I): and type II, Hunter disease (MPS-II). The principal new finding in the brain of the patient with MPS-V is the presence of lesions in the periadventitial mesenchymal tissue of the white matter, similar to those of MPS-I, while the nerve cells in MPS-V are histologically normal, in contradistinction to MPS-I, in which the neuronal abnormality is severe. Electron microscopical studies of the brain in MPS-I demonstrated numerous complex membranous inclusions in the neurons, whereas the neurons in MPS-V contained only a small number of lipofuscin-like inclusions and typical lipofuscin granules. There was a threefold increase of glycosaminoglycans (GAG) in the brain of MPS-I, but only a slight increase in the MPS-V; GAG in the liver and spleen of all patients was noticeably increased. alpha-L-iduronidase activity was not detectable in the brain and liver of patients with MPS-I and MPS-V, thus suggesting a similar enzymatic defect.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Adult
  • Brain / metabolism
  • Brain / pathology*
  • Brain / ultrastructure
  • Cerebral Cortex / ultrastructure
  • Child
  • Dermatan Sulfate / metabolism
  • Diagnosis, Differential
  • Female
  • Glycosaminoglycans / metabolism
  • Heparitin Sulfate / metabolism
  • Humans
  • Iduronidase / metabolism
  • Liver / pathology
  • Male
  • Mucopolysaccharidoses / pathology*
  • Mucopolysaccharidosis I / genetics
  • Mucopolysaccharidosis I / metabolism
  • Mucopolysaccharidosis I / pathology*
  • Mucopolysaccharidosis II / genetics
  • Mucopolysaccharidosis II / metabolism
  • Mucopolysaccharidosis II / pathology*

Substances

  • Glycosaminoglycans
  • Dermatan Sulfate
  • Heparitin Sulfate
  • Iduronidase